Fentanyl self-administration impacts brain immune responses in male Sprague-Dawley rats. 2020

Chiomah Ezeomah, and Kathryn A Cunningham, and Sonja J Stutz, and Robert G Fox, and Natalya Bukreyeva, and Kelly T Dineley, and Slobodan Paessler, and Irma E Cisneros
Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA.

Opioid use disorder (OUD) affects over two million in the United States and is an increasing public health crisis. The abuse of fentanyl and the emergence of potent fentanyl derivatives increases the risk for the user to succumb to overdose, but also to develop OUD. While intense attention is currently focused on understanding the complexity of behaviors and neural functions that contribute to OUD, much remains to be discovered concerning the interactions of opioid intake with the immune response in the central nervous system (CNS). In the present studies, we tested the hypothesis that short-term abstinence from fentanyl self-administration associates with altered expression of innate immune markers. Male Sprague-Dawley rats were trained to self-administer fentanyl (0.0032 mg/kg/infusion) to stability followed by 24 h of abstinence. Several innate immune markers, as well as opioid receptors (ORs) and intracellular pattern recognition receptors (PRRs), were interrogated within nodes of the neurocircuitry involved in OUD processes, including the prefrontal cortex (PFC), nucleus accumbens (NAc), caudate putamen (CPu), hippocampus (HIP) and midbrain (MB). In the present study, few immune targets were impacted in the PFC and MB during short-term abstinence from fentanyl (relative to saline) self-administration. However, increased expression of cytokines [e.g., interleukin (IL)1β, IL5], chemokines [e.g., C-C motif chemokine 20 (MIP3α)], tumor necrosis factor α (TNFα) and interferon (IFN) proteins (e.g., IFNβ and IFNγ)] was seen in the NAc, while decreased expression of cytokines (e.g., several ILs), chemokines [e.g., granulocyte-macrophage colony-stimulating factor (GMCSF), monocyte chemoattractant protein (MCP) MCP1, MIP3α], the chemokine ligand 5 (RANTES) and interferons (e.g., IFNβ and IFNγ) in the HIP. Positive correlations were observed between cumulative fentanyl intake and expression of IL1β and IL6 in the NAc, and significant negative correlations with fentanyl intake and IFN β, IL2, IL5, IL12p70 and IL17 in the HIP. Few changes in OR expression was observed during early abstinence from fentanyl self-administration. Excitingly, the expression of the PRR, stimulator of interferon genes (STING) negatively correlated with cumulative fentanyl intake and significantly correlated to specific cytokines, chemokines and interferon proteins in the HIP. Although the CPu appears relatively invulnerable to changes in innate immune markers, the highest correlations between cumulative fentanyl intake with MAVS and/or STING was measured in the CPu. Our findings provide the first evidence of CNS innate immune responses and implicate STING as novel mechanistic targets of immunomodulation during short-term abstinence from fentanyl self-administration.

UI MeSH Term Description Entries
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005283 Fentanyl A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078) Phentanyl,Duragesic,Durogesic,Fentanest,Fentanyl Citrate,Fentora,R-4263,Sublimaze,Transmucosal Oral Fentanyl Citrate,R 4263,R4263
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018925 Chemokines Class of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; (CHEMOKINES, C); CC; (CHEMOKINES, CC); and CXC; (CHEMOKINES, CXC); according to variations in a shared cysteine motif. Chemokine,Chemotactic Cytokine,Chemotactic Cytokines,Cytokines, Chemotactic,Intercrine,Intercrines,Cytokine, Chemotactic

Related Publications

Chiomah Ezeomah, and Kathryn A Cunningham, and Sonja J Stutz, and Robert G Fox, and Natalya Bukreyeva, and Kelly T Dineley, and Slobodan Paessler, and Irma E Cisneros
April 2018, Psychopharmacology,
Chiomah Ezeomah, and Kathryn A Cunningham, and Sonja J Stutz, and Robert G Fox, and Natalya Bukreyeva, and Kelly T Dineley, and Slobodan Paessler, and Irma E Cisneros
December 2022, International journal of molecular sciences,
Chiomah Ezeomah, and Kathryn A Cunningham, and Sonja J Stutz, and Robert G Fox, and Natalya Bukreyeva, and Kelly T Dineley, and Slobodan Paessler, and Irma E Cisneros
March 2019, Psychopharmacology,
Chiomah Ezeomah, and Kathryn A Cunningham, and Sonja J Stutz, and Robert G Fox, and Natalya Bukreyeva, and Kelly T Dineley, and Slobodan Paessler, and Irma E Cisneros
November 2010, Phytotherapy research : PTR,
Chiomah Ezeomah, and Kathryn A Cunningham, and Sonja J Stutz, and Robert G Fox, and Natalya Bukreyeva, and Kelly T Dineley, and Slobodan Paessler, and Irma E Cisneros
February 2021, Behavioural pharmacology,
Chiomah Ezeomah, and Kathryn A Cunningham, and Sonja J Stutz, and Robert G Fox, and Natalya Bukreyeva, and Kelly T Dineley, and Slobodan Paessler, and Irma E Cisneros
February 2020, Experimental and clinical psychopharmacology,
Chiomah Ezeomah, and Kathryn A Cunningham, and Sonja J Stutz, and Robert G Fox, and Natalya Bukreyeva, and Kelly T Dineley, and Slobodan Paessler, and Irma E Cisneros
March 2003, The Journal of sports medicine and physical fitness,
Chiomah Ezeomah, and Kathryn A Cunningham, and Sonja J Stutz, and Robert G Fox, and Natalya Bukreyeva, and Kelly T Dineley, and Slobodan Paessler, and Irma E Cisneros
March 2000, Toxicological sciences : an official journal of the Society of Toxicology,
Chiomah Ezeomah, and Kathryn A Cunningham, and Sonja J Stutz, and Robert G Fox, and Natalya Bukreyeva, and Kelly T Dineley, and Slobodan Paessler, and Irma E Cisneros
June 2023, Pharmacology, biochemistry, and behavior,
Chiomah Ezeomah, and Kathryn A Cunningham, and Sonja J Stutz, and Robert G Fox, and Natalya Bukreyeva, and Kelly T Dineley, and Slobodan Paessler, and Irma E Cisneros
April 2019, Psychopharmacology,
Copied contents to your clipboard!